SCM
ETON icon

Soleus Capital Management’s Eton Pharmaceutcials ETON Stock Holding History

Soleus Capital Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.11M Buy
+166,381
New +$2.91M 0.17% 67
2025
Q4 		– Sell
-200,000
Closed -$4.35M – 102
2025
Q3 		$4.35M Sell
200,000
-85,000
-30% -$1.41M 0.22% 61
2025
Q2 		$4.06M Buy
+285,000
New +$4.51M 0.27% 57

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Soleus Capital Management's ETON Position: Q1 2026 in Review

Soleus Capital Management opened a new position in Eton Pharmaceutcials (ETON) in Q1 2026: 166,381 shares worth $4.11M. The stake represents 0.17% of the portfolio and ranks #67 among its holdings. This is a return to the name: Soleus Capital Management previously reported a position in ETON as recently as Q3 2025.

Soleus Capital Management first reported a position in ETON in Q2 2025 and has held it in 3 quarters since. The position peaked at $4.35M in Q3 2025. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Soleus Capital Management held 166,381 shares of Eton Pharmaceutcials worth $4.11M as of Q1 2026.
  • Eton Pharmaceutcials was a new Soleus Capital Management position in Q1 2026.
  • Eton Pharmaceutcials made up 0.17% of Soleus Capital Management's portfolio in Q1 2026, its #67 holding.
  • Soleus Capital Management first reported a position in Eton Pharmaceutcials in Q2 2025 and has held it in 3 quarters since.
  • Soleus Capital Management's Eton Pharmaceutcials position peaked at $4.35M in Q3 2025.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Soleus Capital Management's 13F filing for Q1 2026, filed 14 May 2026.